Back to Clinical Trials Overview

Your search for "Mental Health" returned 41 results:


White Matter Abnormalities in the Schizophrenia Spectrum
Principal Investigator(s): Erin Hazlett

Evaluation of NK1 Antagonist in Post-Traumatic Stress
Principal Investigator(s): Dan Iosifescu, MD

Ketamine Plus Lithium as a Novel Pharmacotherapeutic Strategy in Treatment Resistant Depression
Principal Investigator(s): James Murrough, MD

New Directions in the Genetics of Impulsivity and Aggression
Principal Investigator(s): Maria De Las Mercedes Perez-Rodriguez

Neuroendocrine Correlates of Posttraumatic Stress Disorder Before & After Treatment
Principal Investigator(s): Yehuda, Rachel Ph.D.

Cognitive Training for Mood and Anxiety Disorders
Principal Investigator(s): Brian Iacoviello

Cognitive Training in Depression
Principal Investigator(s): Brian Iacoviello

Biological Correlates of Personality Disorder
Principal Investigator(s): Harold Koenigsberg

A 6-Month, Multicenter, Randomized, Safety, Tolerability, Pharmacokinetic, and Preliminary Efficacy Study of AZD5213 in Adolescents with Tourette's Disorder (TD)
Principal Investigator(s): Barbara Coffey

Dopamine and Motivation in Depression
Principal Investigator(s): Dan Iosifescu

Cortisol Augmentation of a Psychological Treatment in Warfighters with Post-traumatic Stress Disorder
Principal Investigator(s): Yehuda, Rachel Ph.D.

Exploring Women's Support and Health Literacy Needs Surrounding Abortion
Principal Investigator(s): Littman, Lisa

An fMRI Study of the Enhancement of Emotion Regulation in Borderline Patients
Principal Investigator(s): Harold W. Koenigsberg

Guanfacine Enhancement of Working Memory: Prospects for Augmenting Cognitive Remediation in the Schizophrenia Spectrum
Principal Investigator(s): Margaret McNamara-McClure

Double-blind, Randomized Study of Extended-release Quetiapine Fumarate (Seroquel XR) in the Treatment of Patients with Comorbid Depression and Anxiety Disorder
Principal Investigator(s): Hirschowitz, Jack

Targeting Circadian and Cognitive Dysfunction in Bipolar Disorder with Modafinil
Principal Investigator(s): Katherine Burdick

A Pilot fMRI Study to Investigate the Impact of Oxytocin Administration on the Behavioral and Neural Mechanisms of Interpersonal Cooperation in Borderline Personality Disorder and Healthy Adults
Principal Investigator(s): Harold Koenigsberg

Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
Principal Investigator(s): Mercedes Perez Rodriguez

Neural and Behavioral Outcomes of Social Skills Groups in Children with ASD
Principal Investigator(s): Wang, A. Ting

Neural Substrate of Emotion in Women with Bulimia Nervosa
Principal Investigator(s): Hildebrandt, Thomas B.

Ketamine as a Rapid Treatment for Post-Traumatic Stress
Principal Investigator(s): Feder, Adriana

An Exploratory Phase II Study to Determine the Safety and Tolerability and activity of a Novel Vasopressin 1a Receptor Antagonist in Adults with DSM-5 Intermittent Explosive Disorder (IED)
Principal Investigator(s): Antonia S. New

Innovative Use of the Noom Monitor Mobile Application for CBT-GSH in Binge Eaters
Principal Investigator(s): Thomas Benjamin Hildebrandt

Understanding Neurocognitive Heterogeneity in Bipolar Disorder
Principal Investigator(s): Katherine Burdick

Perioperative Cognitive Protection-Dexmetomidine
Principal Investigator(s): Deiner, Stacie

A Prospective, Double Blind, Randomized, Controlled Study to Evaluate the Safety and Efficacy of the Deep Transcranial Magnetic Stimulation (DTMS) for the treatment of Obsessive Compulsive Disorder
Principal Investigator(s): Wayne Goodman

Prolonging Remission in Depressed Elderly
Principal Investigator(s): Kellner, Charles

Inflammation, long-term diabetes characteristics, and cognitive decline
Principal Investigator(s): Schnaider-Beeri, Michal

Online Group Treatment of Emotional Dyscontrol
Principal Investigator(s): Jason Krellman

A Randomized, Double-blind, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of STX209 (Arbaclofen) Administered for the Treatment of Social Withdrawal in Children with Fragile X Syndrome
Principal Investigator(s): Alexander Kolevzon

A Prospective, Double Blind, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of the H1-Coil deep Transcranial Magnetic Stimulation (TMS) in conjunction with mood stabilizers in Subjects with Bipolar Depression
Principal Investigator(s): Dan Iosifescu

Computerized cognitive intervention in the oldest-old: A feasibility study
Principal Investigator(s): Michal Schnaider-Beeri

A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression
Principal Investigator(s): Wayne Goodman

Reclaim Deep Brain Stimulation Therapy for Obsessive-Compulsive Disorder
Principal Investigator(s): Goodman, Wayne

The Efficacy and Safety of Galantamine for Dysfunction in Bipolar Disorder
Principal Investigator(s): Dan Iosifescu, MD

Behavioral and fMRI studies of cognition in healthy individuals and patients with anxiety
Principal Investigator(s): Emily Stern

A D1 Agonist for Working Memory Enhancement in the Schizophrenia
Principal Investigator(s): Antonia S. New

Impact of intraoperative blood pressure on cognitive performance in patients with and without hypertension a prospective observational study
Principal Investigator(s): Deiner, Stacie

COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients
Principal Investigator(s): Davidson, Karina

Phase 2A Study to Evaluate the Kappa Opioid Receptor as a Target for the Treatment of Mood and Anxiety Spectrum Disorders By Evaluating Whether LY2456302 Engages Reward-related Neural Circuitry
Principal Investigator(s): Wayne Goodman

Pharmacology of Cognition in Schizotypal Personality
Principal Investigator(s): Siever, Larry J